The unsealed documents reveal that AstraZeneca “buried” unfavorable studies that showed Seroquel posed a serious risk for diabetes.Read More
A document filed in Federal District Court, Orlando Fla, by plaintiffs "in response to AstraZeneca’s motion to exclude evidence and argument about Dr. Macfadden’s personal relationships," sheds light on yet another facet of manipulation–sexual exploitation.Read More
A federal Judge of the Eastern District (Brooklyn) issued a ruling upholding a seal on documents that contain evidence linking Zyprexa, Eli Lilly's antipsychotic drug to diabetesRead More
Despite Lilly's efforts to suppress the documents, they are available on internet websites.
Judge Jack Weinstein rejected Lilly's effort to seek a court injunction against internet posting
of the documents.
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller.Read More
“No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal…"Read More
Two ground breaking legal actions in Texas to rein in out of control psychotropic drug prescribing will have nationwide reverberations.Read More
Unssuccessful effort to engage debate within the community of the authorized clinical research gatekeepers charged with protecting the safety and welfare of the human subjects of research–i.e., members of institutional review boards (IRBs–REBs in Canada).Read More
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.Read More
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability Project Creates “FactSquad” on Rx…Read More
Pfizer Fires a Vice President Who Criticized Company’s Sales Practices Fri, 2 Dec 2005 Word of the day: “The Department of Justice simply does not have enough lawyers and investigators to handle the volume of false claims act suits coming its way. There are right now 150 cases under seal and under investigation, covering more…Read More
<p> Big Pharma’s Shameful Secret – Bloomberg News <br> Most Clinical Trials Stopped Early for “perceived” benefit later turned out false – JAMA </p> <p> Thu, 3 Nov 2005 </p> <p> A six part Special Report by Bloomberg News reveals that “Every year, drug companies spend $14 billion to test experimental substances on humans. Across…Read More